Table of Contents 1 Bio Pharma Buffer Market Overview 1.1 Product Overview and Scope of Bio Pharma Buffer 1.2 Bio Pharma Buffer Segment by Type 1.2.1 Global Bio Pharma Buffer Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Phosphates Type 1.2.3 Acetates Type 1.2.4 TRIS Type 1.2.5 Others 1.3 Bio Pharma Buffer Segment by Application 1.3.1 Bio Pharma Buffer Sales Comparison by Application: 2020 VS 2026 1.3.2 Research Institution 1.3.3 Pharmaceutical Industry 1.3.4 Others 1.4 Global Bio Pharma Buffer Market Size Estimates and Forecasts 1.4.1 Global Bio Pharma Buffer Revenue 2015-2026 1.4.2 Global Bio Pharma Buffer Sales 2015-2026 1.4.3 Bio Pharma Buffer Market Size by Region: 2020 Versus 2026 2 Global Bio Pharma Buffer Market Competition by Manufacturers 2.1 Global Bio Pharma Buffer Sales Market Share by Manufacturers (2015-2020) 2.2 Global Bio Pharma Buffer Revenue Share by Manufacturers (2015-2020) 2.3 Global Bio Pharma Buffer Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Bio Pharma Buffer Manufacturing Sites, Area Served, Product Type 2.5 Bio Pharma Buffer Market Competitive Situation and Trends 2.5.1 Bio Pharma Buffer Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Bio Pharma Buffer Players (Opinion Leaders) 3 Bio Pharma Buffer Retrospective Market Scenario by Region 3.1 Global Bio Pharma Buffer Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Bio Pharma Buffer Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Bio Pharma Buffer Market Facts & Figures by Country 3.3.1 North America Bio Pharma Buffer Sales by Country 3.3.2 North America Bio Pharma Buffer Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Bio Pharma Buffer Market Facts & Figures by Country 3.4.1 Europe Bio Pharma Buffer Sales by Country 3.4.2 Europe Bio Pharma Buffer Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Bio Pharma Buffer Market Facts & Figures by Region 3.5.1 Asia Pacific Bio Pharma Buffer Sales by Region 3.5.2 Asia Pacific Bio Pharma Buffer Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Bio Pharma Buffer Market Facts & Figures by Country 3.6.1 Latin America Bio Pharma Buffer Sales by Country 3.6.2 Latin America Bio Pharma Buffer Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Bio Pharma Buffer Market Facts & Figures by Country 3.7.1 Middle East and Africa Bio Pharma Buffer Sales by Country 3.7.2 Middle East and Africa Bio Pharma Buffer Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Bio Pharma Buffer Historic Market Analysis by Type 4.1 Global Bio Pharma Buffer Sales Market Share by Type (2015-2020) 4.2 Global Bio Pharma Buffer Revenue Market Share by Type (2015-2020) 4.3 Global Bio Pharma Buffer Price Market Share by Type (2015-2020) 4.4 Global Bio Pharma Buffer Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Bio Pharma Buffer Historic Market Analysis by Application 5.1 Global Bio Pharma Buffer Sales Market Share by Application (2015-2020) 5.2 Global Bio Pharma Buffer Revenue Market Share by Application (2015-2020) 5.3 Global Bio Pharma Buffer Price by Application (2015-2020) 6 Company Profiles and Key Figures in Bio Pharma Buffer Business 6.1 Avantor 6.1.1 Corporation Information 6.1.2 Avantor Description, Business Overview and Total Revenue 6.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Avantor Products Offered 6.1.5 Avantor Recent Development 6.2 Alfa Aesar (Thermo Fisher) 6.2.1 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Production Sites and Area Served 6.2.2 Alfa Aesar (Thermo Fisher) Description, Business Overview and Total Revenue 6.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Alfa Aesar (Thermo Fisher) Products Offered 6.2.5 Alfa Aesar (Thermo Fisher) Recent Development 6.3 Merck 6.3.1 Merck Bio Pharma Buffer Production Sites and Area Served 6.3.2 Merck Description, Business Overview and Total Revenue 6.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Merck Products Offered 6.3.5 Merck Recent Development 6.4 Lonza 6.4.1 Lonza Bio Pharma Buffer Production Sites and Area Served 6.4.2 Lonza Description, Business Overview and Total Revenue 6.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Lonza Products Offered 6.4.5 Lonza Recent Development 6.5 Bio-Rad 6.5.1 Bio-Rad Bio Pharma Buffer Production Sites and Area Served 6.5.2 Bio-Rad Description, Business Overview and Total Revenue 6.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Bio-Rad Products Offered 6.5.5 Bio-Rad Recent Development 6.6 BD 6.6.1 BD Bio Pharma Buffer Production Sites and Area Served 6.6.2 BD Description, Business Overview and Total Revenue 6.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.6.4 BD Products Offered 6.6.5 BD Recent Development 6.7 GE Healthcare 6.6.1 GE Healthcare Bio Pharma Buffer Production Sites and Area Served 6.6.2 GE Healthcare Description, Business Overview and Total Revenue 6.6.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.4.4 GE Healthcare Products Offered 6.7.5 GE Healthcare Recent Development 6.8 Promega Corporation 6.8.1 Promega Corporation Bio Pharma Buffer Production Sites and Area Served 6.8.2 Promega Corporation Description, Business Overview and Total Revenue 6.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Promega Corporation Products Offered 6.8.5 Promega Corporation Recent Development 6.9 Hamilton Company 6.9.1 Hamilton Company Bio Pharma Buffer Production Sites and Area Served 6.9.2 Hamilton Company Description, Business Overview and Total Revenue 6.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Hamilton Company Products Offered 6.9.5 Hamilton Company Recent Development 6.10 XZL BIO-TECHNOLOGY 6.10.1 XZL BIO-TECHNOLOGY Bio Pharma Buffer Production Sites and Area Served 6.10.2 XZL BIO-TECHNOLOGY Description, Business Overview and Total Revenue 6.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.10.4 XZL BIO-TECHNOLOGY Products Offered 6.10.5 XZL BIO-TECHNOLOGY Recent Development 6.11 SRL 6.11.1 SRL Bio Pharma Buffer Production Sites and Area Served 6.11.2 SRL Bio Pharma Buffer Description, Business Overview and Total Revenue 6.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020) 6.11.4 SRL Products Offered 6.11.5 SRL Recent Development 7 Bio Pharma Buffer Manufacturing Cost Analysis 7.1 Bio Pharma Buffer Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Bio Pharma Buffer 7.4 Bio Pharma Buffer Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Bio Pharma Buffer Distributors List 8.3 Bio Pharma Buffer Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Bio Pharma Buffer Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Bio Pharma Buffer by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Bio Pharma Buffer by Type (2021-2026) 10.2 Bio Pharma Buffer Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Bio Pharma Buffer by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Bio Pharma Buffer by Application (2021-2026) 10.3 Bio Pharma Buffer Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Bio Pharma Buffer by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Bio Pharma Buffer by Region (2021-2026) 10.4 North America Bio Pharma Buffer Estimates and Projections (2021-2026) 10.5 Europe Bio Pharma Buffer Estimates and Projections (2021-2026) 10.6 Asia Pacific Bio Pharma Buffer Estimates and Projections (2021-2026) 10.7 Latin America Bio Pharma Buffer Estimates and Projections (2021-2026) 10.8 Middle East and Africa Bio Pharma Buffer Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Bio Pharma Buffer Sales (kL) Growth Rate Comparison by Type (2015-2026) Table 2. Global Bio Pharma Buffer Sales (kL) Comparison by Application: 2020 VS 2026 Table 3. Global Bio Pharma Buffer Market Size by Type (kL) (US$ Million) (2020 VS 2026) Table 4. Global Key Bio Pharma Buffer Manufacturers Covered in This Study Table 5. Global Bio Pharma Buffer Sales (kL) by Manufacturers (2015-2020) Table 6. Global Bio Pharma Buffer Sales Share by Manufacturers (2015-2020) Table 7. Global Bio Pharma Buffer Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Bio Pharma Buffer Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Bio Pharma Buffer Average Price (USD/L) of Key Manufacturers (2015-2020) Table 10. Manufacturers Bio Pharma Buffer Sales Sites and Area Served Table 11. Manufacturers Bio Pharma Buffer Product Types Table 12. Global Bio Pharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Pharma Buffer as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Bio Pharma Buffer Players Table 16. Global Bio Pharma Buffer Sales (kL) by Region (2015-2020) Table 17. Global Bio Pharma Buffer Sales Market Share by Region (2015-2020) Table 18. Global Bio Pharma Buffer Revenue (Million US$) by Region (2015-2020) Table 19. Global Bio Pharma Buffer Revenue Market Share by Region (2015-2020) Table 20. North America Bio Pharma Buffer Sales by Country (2015-2020) (kL) Table 21. North America Bio Pharma Buffer Sales Market Share by Country (2015-2020) Table 22. North America Bio Pharma Buffer Revenue by Country (2015-2020) (US$ Million) Table 23. North America Bio Pharma Buffer Revenue Market Share by Country (2015-2020) Table 24. Europe Bio Pharma Buffer Sales by Country (2015-2020) (kL) Table 25. Europe Bio Pharma Buffer Sales Market Share by Country (2015-2020) Table 26. Europe Bio Pharma Buffer Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Bio Pharma Buffer Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Bio Pharma Buffer Sales by Region (2015-2020) (kL) Table 29. Asia Pacific Bio Pharma Buffer Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Bio Pharma Buffer Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Bio Pharma Buffer Revenue Market Share by Region (2015-2020) Table 32. Latin America Bio Pharma Buffer Sales by Country (2015-2020) (kL) Table 33. Latin America Bio Pharma Buffer Sales Market Share by Country (2015-2020) Table 34. Latin America Bio Pharma Buffer Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Bio Pharma Buffer Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Bio Pharma Buffer Sales by Country (2015-2020) (kL) Table 37. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Bio Pharma Buffer Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Country (2015-2020) Table 40. Global Bio Pharma Buffer Sales (kL) by Type (2015-2020) Table 41. Global Bio Pharma Buffer Sales Share by Type (2015-2020) Table 42. Global Bio Pharma Buffer Revenue (Million US$) by Type (2015-2020) Table 43. Global Bio Pharma Buffer Revenue Share by Type (2015-2020) Table 44. Global Bio Pharma Buffer Price (USD/L) by Type (2015-2020) Table 45. Global Bio Pharma Buffer Sales (kL) by Application (2015-2020) Table 46. Global Bio Pharma Buffer Sales Market Share by Application (2015-2020) Table 47. Global Bio Pharma Buffer Sales Growth Rate by Application (2015-2020) Table 48. Avantor Bio Pharma Buffer Corporation Information Table 49. Avantor Description and Business Overview Table 50. Avantor Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 51. Avantor Main Product Table 52. Avantor Recent Development Table 53. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Corporation Information Table 54. Alfa Aesar (Thermo Fisher) Corporation Information Table 55. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 56. Alfa Aesar (Thermo Fisher) Main Product Table 57. Alfa Aesar (Thermo Fisher) Recent Development Table 58. Merck Bio Pharma Buffer Corporation Information Table 59. Merck Corporation Information Table 60. Merck Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 61. Merck Main Product Table 62. Merck Recent Development Table 63. Lonza Bio Pharma Buffer Corporation Information Table 64. Lonza Corporation Information Table 65. Lonza Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 66. Lonza Main Product Table 67. Lonza Recent Development Table 68. Bio-Rad Bio Pharma Buffer Corporation Information Table 69. Bio-Rad Corporation Information Table 70. Bio-Rad Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 71. Bio-Rad Main Product Table 72. Bio-Rad Recent Development Table 73. BD Bio Pharma Buffer Corporation Information Table 74. BD Corporation Information Table 75. BD Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 76. BD Main Product Table 77. BD Recent Development Table 78. GE Healthcare Bio Pharma Buffer Corporation Information Table 79. GE Healthcare Corporation Information Table 80. GE Healthcare Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 81. GE Healthcare Main Product Table 82. GE Healthcare Recent Development Table 83. Promega Corporation Bio Pharma Buffer Corporation Information Table 84. Promega Corporation Corporation Information Table 85. Promega Corporation Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 86. Promega Corporation Main Product Table 87. Promega Corporation Recent Development Table 88. Hamilton Company Bio Pharma Buffer Corporation Information Table 89. Hamilton Company Corporation Information Table 90. Hamilton Company Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 91. Hamilton Company Main Product Table 92. Hamilton Company Recent Development Table 93. XZL BIO-TECHNOLOGY Bio Pharma Buffer Corporation Information Table 94. XZL BIO-TECHNOLOGY Corporation Information Table 95. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 96. XZL BIO-TECHNOLOGY Main Product Table 97. XZL BIO-TECHNOLOGY Recent Development Table 98. SRL Bio Pharma Buffer Corporation Information Table 99. SRL Corporation Information Table 100. SRL Bio Pharma Buffer Sales (kL), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020) Table 101. SRL Main Product Table 102. SRL Recent Development Table 103. Sales Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Bio Pharma Buffer Distributors List Table 106. Bio Pharma Buffer Customers List Table 107. Market Key Trends Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 109. Key Challenges Table 110. Global Bio Pharma Buffer Sales (kL) Forecast by Type (2021-2026) Table 111. Global Bio Pharma Buffer Sales Market Share Forecast by Type (2021-2026) Table 112. Global Bio Pharma Buffer Revenue (Million US$) Forecast by Type (2021-2026) Table 113. Global Bio Pharma Buffer Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 114. Global Bio Pharma Buffer Sales (kL) Forecast by Application (2021-2026) Table 115. Global Bio Pharma Buffer Revenue (Million US$) Forecast by Application (2021-2026) Table 116. Global Bio Pharma Buffer Sales (kL) Forecast by Region (2021-2026) Table 117. Global Bio Pharma Buffer Sales Market Share Forecast by Region (2021-2026) Table 118. Global Bio Pharma Buffer Revenue Forecast by Region (2021-2026) (US$ Million) Table 119. Global Bio Pharma Buffer Revenue Market Share Forecast by Region (2021-2026) Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Bio Pharma Buffer Figure 2. Global Bio Pharma Buffer Sales Market Share by Type: 2020 VS 2026 Figure 3. Phosphates Type Product Picture Figure 4. Acetates Type Product Picture Figure 5. TRIS Type Product Picture Figure 6. Others Product Picture Figure 7. Global Bio Pharma Buffer Consumption Market Share by Application: 2020 VS 2026 Figure 8. Research Institution Figure 9. Pharmaceutical Industry Figure 10. Others Figure 11. Global Bio Pharma Buffer Market Size 2015-2026 (US$ Million) Figure 12. Global Bio Pharma Buffer Sales Capacity (kL) (2015-2026) Figure 13. Global Bio Pharma Buffer Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Bio Pharma Buffer Sales Share by Manufacturers in 2020 Figure 15. Global Bio Pharma Buffer Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by Bio Pharma Buffer Revenue in 2019 Figure 17. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Bio Pharma Buffer Sales Market Share by Region (2015-2020) Figure 19. Global Bio Pharma Buffer Sales Market Share by Region in 2019 Figure 20. Global Bio Pharma Buffer Revenue Market Share by Region (2015-2020) Figure 21. Global Bio Pharma Buffer Revenue Market Share by Region in 2019 Figure 22. North America Bio Pharma Buffer Sales Market Share by Country in 2019 Figure 23. North America Bio Pharma Buffer Revenue Market Share by Country in 2019 Figure 24. U.S. Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 25. U.S. Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 27. Canada Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe Bio Pharma Buffer Sales Market Share by Country in 2019 Figure 29. Europe Bio Pharma Buffer Revenue Market Share by Country in 2019 Figure 30. Germany Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 31. Germany Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 33. France Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 35. U.K. Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 37. Italy Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 39. Russia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific Bio Pharma Buffer Sales Market Share by Region in 2019 Figure 41. Asia Pacific Bio Pharma Buffer Revenue Market Share by Region in 2019 Figure 42. China Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 43. China Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 45. Japan Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 47. South Korea Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 49. India Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 51. Australia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 53. Taiwan Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 55. Indonesia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 57. Thailand Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 59. Malaysia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 61. Philippines Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 63. Vietnam Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America Bio Pharma Buffer Sales Market Share by Country in 2019 Figure 65. Latin America Bio Pharma Buffer Revenue Market Share by Country in 2019 Figure 66. Mexico Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 67. Mexico Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 69. Brazil Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 71. Argentina Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country in 2019 Figure 73. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Country in 2019 Figure 74. Turkey Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 75. Turkey Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 77. Saudi Arabia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL) Figure 79. U.A.E Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of Bio Pharma Buffer by Type (2015-2020) Figure 81. Sales Market Share of Bio Pharma Buffer by Type in 2019 Figure 82. Revenue Share of Bio Pharma Buffer by Type (2015-2020) Figure 83. Revenue Market Share of Bio Pharma Buffer by Type in 2019 Figure 84. Global Bio Pharma Buffer Sales Growth by Type (2015-2020) (kL) Figure 85. Global Bio Pharma Buffer Sales Market Share by Application (2015-2020) Figure 86. Global Bio Pharma Buffer Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of Bio Pharma Buffer by Application (2015-2020) Figure 88. Global Revenue Share of Bio Pharma Buffer by Application in 2020 Figure 89. Avantor Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Alfa Aesar (Thermo Fisher) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Lonza Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. BD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Promega Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Hamilton Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. XZL BIO-TECHNOLOGY Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. SRL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Price Trend of Key Raw Materials Figure 101. Manufacturing Cost Structure of Bio Pharma Buffer Figure 102. Manufacturing Process Analysis of Bio Pharma Buffer Figure 103. Bio Pharma Buffer Industrial Chain Analysis Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Porter's Five Forces Analysis Figure 107. North America Bio Pharma Buffer Sales (kL) and Growth Rate Forecast (2021-2026) Figure 108. North America Bio Pharma Buffer Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Europe Bio Pharma Buffer Sales (kL) and Growth Rate Forecast (2021-2026) Figure 110. Europe Bio Pharma Buffer Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Bio Pharma Buffer Sales (kL) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Bio Pharma Buffer Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Bio Pharma Buffer Sales (kL) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Bio Pharma Buffer Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Bio Pharma Buffer Sales (kL) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Bio Pharma Buffer Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Bottom-up and Top-down Approaches for This Report Figure 118. Data Triangulation Figure 119. Key Executives Interviewed

Avantor Alfa Aesar (Thermo Fisher) Merck Lonza Bio-Rad BD GE Healthcare Promega Corporation Hamilton Company XZL BIO-TECHNOLOGY SRL